BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

578 related articles for article (PubMed ID: 28364958)

  • 1. Validation of the Spanish-language version of the Montreal Cognitive Assessment test in adults older than 60 years.
    Delgado C; Araneda A; Behrens MI
    Neurologia (Engl Ed); 2019; 34(6):376-385. PubMed ID: 28364958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validity and Reliability of the Spanish Version of the Montreal Cognitive Assessment (MoCA) for the Detection of Cognitive Impairment in Mexico.
    Aguilar-Navarro SG; Mimenza-Alvarado AJ; Palacios-García AA; Samudio-Cruz A; Gutiérrez-Gutiérrez LA; Ávila-Funes JA
    Rev Colomb Psiquiatr (Engl Ed); 2018; 47(4):237-243. PubMed ID: 30286846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validity and reliability of the Persian version of the Montreal Cognitive Assessment (MoCA-P) scale among subjects with Parkinson's disease.
    Badrkhahan SZ; Sikaroodi H; Sharifi F; Kouti L; Noroozian M
    Appl Neuropsychol Adult; 2020; 27(5):431-439. PubMed ID: 30821505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of Montreal Cognitive Assessment and Discriminant Power of Montreal Cognitive Assessment Subtests in Patients With Mild Cognitive Impairment and Alzheimer Dementia in Turkish Population.
    Kaya Y; Aki OE; Can UA; Derle E; Kibaroğlu S; Barak A
    J Geriatr Psychiatry Neurol; 2014 Jun; 27(2):103-9. PubMed ID: 24578463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy and Psychometric Properties of the Brazilian Version of the Montreal Cognitive Assessment as a Brief Screening Tool for Mild Cognitive Impairment and Alzheimer's Disease in the Initial Stages in the Elderly.
    Pinto TCC; Machado L; Costa MLG; Santos MSP; Bulgacov TM; Rolim APP; Silva GA; Rodrigues-Júnior AL; Sougey EB; Ximenes RCC
    Dement Geriatr Cogn Disord; 2019; 47(4-6):366-374. PubMed ID: 31466064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the Montreal Cognitive Assessment (MoCA) in Spanish as a screening tool for mild cognitive impairment and mild dementia in patients over 65 years old in Bogotá, Colombia.
    Gil L; Ruiz de Sánchez C; Gil F; Romero SJ; Pretelt Burgos F
    Int J Geriatr Psychiatry; 2015 Jun; 30(6):655-62. PubMed ID: 25320026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the Montreal Cognitive Assessment (MoCA) test better suited than the Mini-Mental State Examination (MMSE) in mild cognitive impairment (MCI) detection among people aged over 60? Meta-analysis.
    Ciesielska N; Sokołowski R; Mazur E; Podhorecka M; Polak-Szabela A; Kędziora-Kornatowska K
    Psychiatr Pol; 2016 Oct; 50(5):1039-1052. PubMed ID: 27992895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validity of the Cantonese Chinese Montreal Cognitive Assessment in Southern Chinese.
    Chu LW; Ng KH; Law AC; Lee AM; Kwan F
    Geriatr Gerontol Int; 2015 Jan; 15(1):96-103. PubMed ID: 24456109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the Montreal Cognitive Assessment (MoCA) and its memory tasks for detecting mild cognitive impairment.
    Li X; Jia S; Zhou Z; Jin Y; Zhang X; Hou C; Zheng W; Rong P; Jiao J
    Neurol Sci; 2018 Jun; 39(6):1029-1034. PubMed ID: 29550982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the Turkish Version of the Montreal Cognitive Assessment Scale (MoCA-TR) in patients with Parkinson's disease.
    Ozdilek B; Kenangil G
    Clin Neuropsychol; 2014; 28(2):333-43. PubMed ID: 24528299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychometrics and diagnostic properties of the Montreal Cognitive Assessment 5-min protocol in screening for Mild Cognitive Impairment and dementia among older adults in Tanzania: A validation study.
    Masika GM; Yu DSF; Li PWC; Wong A; Lin RSY
    Int J Older People Nurs; 2021 Jan; 16(1):e12348. PubMed ID: 32920984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of the Montreal Cognitive Assessment Thai Version to Discriminate Amnestic Mild Cognitive Impairment from Alzheimer's Disease and Healthy Controls: Machine Learning Results.
    Hemrungrojn S; Tangwongchai S; Charoenboon T; Panasawat M; Supasitthumrong T; Chaipresertsud P; Maleevach P; Likitjaroen Y; Phanthumchinda K; Maes M
    Dement Geriatr Cogn Disord; 2021; 50(2):183-194. PubMed ID: 34325427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic utility of the Addenbrooke's Cognitive Examination - III (ACE-III), Mini-ACE, Mini-Mental State Examination, Montreal Cognitive Assessment, and Hasegawa Dementia Scale-Revised for detecting mild cognitive impairment and dementia.
    Senda M; Terada S; Takenoshita S; Hayashi S; Yabe M; Imai N; Horiuchi M; Yamada N
    Psychogeriatrics; 2020 Mar; 20(2):156-162. PubMed ID: 31448862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal cutoff scores for dementia and mild cognitive impairment of the Montreal Cognitive Assessment among elderly and oldest-old Chinese population.
    Tan JP; Li N; Gao J; Wang LN; Zhao YM; Yu BC; Du W; Zhang WJ; Cui LQ; Wang QS; Li JJ; Yang JS; Yu JM; Xia XN; Zhou PY
    J Alzheimers Dis; 2015; 43(4):1403-12. PubMed ID: 25147113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Beijing version of the Montreal Cognitive Assessment as a brief screening tool for mild cognitive impairment: a community-based study.
    Yu J; Li J; Huang X
    BMC Psychiatry; 2012 Sep; 12():156. PubMed ID: 23009126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Argentinian/Chilean validation of the Spanish-language version of Addenbrooke's Cognitive Examination III for diagnosing dementia.
    Bruno D; Slachevsky A; Fiorentino N; Rueda DS; Bruno G; Tagle AR; Olavarria L; Flores P; Lillo P; Roca M; Torralva T
    Neurologia (Engl Ed); 2020 Mar; 35(2):82-88. PubMed ID: 28865943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychometric and diagnostic properties of the Taiwan version of the Quick Mild Cognitive Impairment screen.
    Lee MT; Chang WY; Jang Y
    PLoS One; 2018; 13(12):e0207851. PubMed ID: 30507928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validity of the Georgian Montreal Cognitive Assessment for the Screening of Mild Cognitive Impairment and Dementia.
    Janelidze M; Mikeladze N; Bochorishvili N; Dzagnidze A; Kapianidze M; Mikava N; Khatiashvili I; Kakhiani D; Mirvelashvili E; Shiukashvili N; Nadareishvili Z
    Am J Alzheimers Dis Other Demen; 2017 Feb; 32(1):36-40. PubMed ID: 27909150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of the Slovenian version of the Montreal Cognitive Assessment Scale as a screening tool for the detection of mild cognitive impairment.
    Špeh A; Kalar I; Pirtošek Z; Kramberger MG
    Acta Neurol Belg; 2024 Apr; 124(2):543-547. PubMed ID: 38436822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study of two Chinese versions of Montreal Cognitive Assessment for Screening of Mild Cognitive Impairment.
    Huang YY; Qian SX; Guan QB; Chen KL; Zhao QH; Lu JH; Guo QH
    Appl Neuropsychol Adult; 2021; 28(1):88-93. PubMed ID: 31014115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.